Kintor Pharma Receives IND Clearance by NMPA for KX-826's Pivotal Study to Treat Male Alopecia Patients

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Related Keywords

China ,United States ,Peking ,Beijing ,Suzhou ,Jiangsu ,Kintor Pharma ,Zhang Jianzhong ,Yang Qinping ,Ir Team ,Kintor Pharmaceutical ,University People Hospital ,Huashan Hospital Of Fudan University ,Prnewswire Kintor Pharmaceutical Limited Pharma ,Pr Team ,National Medical Products Administration ,Drug Administration Of The United States ,Pharmaceutical Limited ,Professor Zhang Jianzhong ,Peking University People ,Director Yang Qinping ,Huashan Hospital ,Drug Administration ,Business ,Health ,Pr Newswire ,Clinical Trials ,